ClearPoint Neuro, Inc.

US$8.60As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CLPTHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 5.88%
Div yield —
ROE (167.52%)
Medical Devices
Beta (5Y) 1.36
PE TTM —
TSR TTM (62.96%)
Mkt cap US$275.7M
ROIC (24.82%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.54
(0.69%)
(42.18%)
Hold 2|2|6|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.14
0.14
10.02%
23.61%
23.35%
31.95%
Revenue$M
15.22
15.02
15.84
16.59
3.91%
4.91%
4.39%
10.15%
Peers (US$275.7M)
Cap (US$)
PE
274.2M
31.10x
262.1M
—
276.0M
7.401x
Capital
TTM
5Y
10Y
Leveragex
0.740
0.763
0.767
EBIT/Intx
0.054
0.120
0.152
Own earn%
35.30
(127.94)
(113.68)
Sh yield%
36.06
44.76
42.61
Owners
Insiders/Inst%
13.22
81.46
Short interest%
3.43
SBC / revenue%
0.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
23–30
$1 testx
—
Incr. ROIC%
1